Everolimus Related Compound 2 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin is a metabolite of the immunosuppressant macrolide SDZ RAD (also known as Everolimus E945400) which is an analog of the parent drug Rapamycin (R124000).

Everolimus Related Compound 2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Everolimus Related Compound 2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
Guangzhou CATO Research Chemicals Inc.	+86-020-81960175-617 +8615602392859	Intermediate@cato-chem.com	China	8322	58
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	24342	58
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18070	56
Nanjing XiZe Biotechnology CO., Ltd.	025-66023220 0086-15250997978	1511893459@qq.com	China	7892	55
Shanghai Rechem science Co., Ltd.	21-31433387 15618786686	sales@rechemscience.com	China	2989	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57423	58
Guangzhou Dreampharm Biotechnology Co., Ltd.	020-36607679 17825480238	3008233746@qq.com	China	9919	12
Suzhou XiBoli Biotechnology Co., Ltd.	17326194005	1873444526@qq.com	China	491	58

1062122-63-7()Verwandte Suche:

---

• 2-Piperidinecarboxylic acid, 1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]ace...
• (19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin Discontinued. please offer H825290
• Everolimus Impurity 4（804-95）
• Everolimus EP Impurity B (804-95)
• (S)-1-(2-((2R,3R,6S)-2-Hydroxy-6-((2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl)-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid (Everolimus Impurity)
• Everolimus Impurity 4 (Everolimus EP Impurity B) (804-95)
• Everolimus Related Compound 2
• EVEROLIMUS EP IMPURITY B/ EVEROLIMUS-19-ENE OPEN RING
• 1062122-63-7